412 related articles for article (PubMed ID: 10677309)
1. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility.
Broeks A; Urbanus JH; Floore AN; Dahler EC; Klijn JG; Rutgers EJ; Devilee P; Russell NS; van Leeuwen FE; van 't Veer LJ
Am J Hum Genet; 2000 Feb; 66(2):494-500. PubMed ID: 10677309
[TBL] [Abstract][Full Text] [Related]
2. Contribution of mutations in ATM to breast cancer development in the Czech population.
Soukupova J; Dundr P; Kleibl Z; Pohlreich P
Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
[TBL] [Abstract][Full Text] [Related]
3. IVS10-6T>G, an ancient ATM germline mutation linked with breast cancer.
Broeks A; Urbanus JH; de Knijff P; Devilee P; Nicke M; Klöpper K; Dörk T; Floore AN; van't Veer LJ
Hum Mutat; 2003 May; 21(5):521-8. PubMed ID: 12673794
[TBL] [Abstract][Full Text] [Related]
4. Dominant negative ATM mutations in breast cancer families.
Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
[TBL] [Abstract][Full Text] [Related]
6. Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families.
Lindeman GJ; Hiew M; Visvader JE; Leary J; Field M; Gaff CL; Gardner RJ; Trainor K; Cheetham G; Suthers G; Kirk J
Breast Cancer Res; 2004; 6(4):R401-7. PubMed ID: 15217508
[TBL] [Abstract][Full Text] [Related]
7. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
8. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous ATM mutations do not contribute to early onset of breast cancer.
FitzGerald MG; Bean JM; Hegde SR; Unsal H; MacDonald DJ; Harkin DP; Finkelstein DM; Isselbacher KJ; Haber DA
Nat Genet; 1997 Mar; 15(3):307-10. PubMed ID: 9054948
[TBL] [Abstract][Full Text] [Related]
10. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
11. Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
Szabo CI; Schutte M; Broeks A; Houwing-Duistermaat JJ; Thorstenson YR; Durocher F; Oldenburg RA; Wasielewski M; Odefrey F; Thompson D; Floore AN; Kraan J; Klijn JG; van den Ouweland AM; Wagner TM; Devilee P; Simard J; van 't Veer LJ; Goldgar DE; Meijers-Heijboer H
Cancer Res; 2004 Feb; 64(3):840-3. PubMed ID: 14871810
[TBL] [Abstract][Full Text] [Related]
12. ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay.
Drumea KC; Levine E; Bernstein J; Shank B; Green S; Kaplan E; Mandell L; Cropley J; Obropta J; Braccia I; Krupnik A; Rosenstein BS
Breast Cancer Res Treat; 2000 May; 61(1):79-85. PubMed ID: 10930092
[TBL] [Abstract][Full Text] [Related]
13. Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history.
Teraoka SN; Malone KE; Doody DR; Suter NM; Ostrander EA; Daling JR; Concannon P
Cancer; 2001 Aug; 92(3):479-87. PubMed ID: 11505391
[TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity in bilateral breast cancer.
Kollias J; Man S; Marafie M; Carpenter K; Pinder S; Ellis IO; Blamey RW; Cross G; Brook JD
Breast Cancer Res Treat; 2000 Dec; 64(3):241-51. PubMed ID: 11200774
[TBL] [Abstract][Full Text] [Related]
15. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer.
Izatt L; Greenman J; Hodgson S; Ellis D; Watts S; Scott G; Jacobs C; Liebmann R; Zvelebil MJ; Mathew C; Solomon E
Genes Chromosomes Cancer; 1999 Dec; 26(4):286-94. PubMed ID: 10534763
[TBL] [Abstract][Full Text] [Related]
16. ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
Bernstein JL; Bernstein L; Thompson WD; Lynch CF; Malone KE; Teitelbaum SL; Olsen JH; Anton-Culver H; Boice JD; Rosenstein BS; Børresen-Dale AL; Gatti RA; Concannon P; Haile RW;
Br J Cancer; 2003 Oct; 89(8):1513-6. PubMed ID: 14562025
[TBL] [Abstract][Full Text] [Related]
17. Association of common ATM polymorphism with bilateral breast cancer.
Heikkinen K; Rapakko K; Karppinen SM; Erkko H; Nieminen P; Winqvist R
Int J Cancer; 2005 Aug; 116(1):69-72. PubMed ID: 15756685
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of breast cancer following irradiation for Hodgkin's disease is not a result of ATM germline mutations.
Broeks A; Russell NS; Floore AN; Urbanus JH; Dahler EC; van T Veer MB; Hagenbeek A; Noordijk EM; Crommelin MA; van Leeuwen FE; van T Veer LJ
Int J Radiat Biol; 2000 May; 76(5):693-8. PubMed ID: 10866292
[TBL] [Abstract][Full Text] [Related]
19. Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Renault AL; Mebirouk N; Fuhrmann L; Bataillon G; Cavaciuti E; Le Gal D; Girard E; Popova T; La Rosa P; Beauvallet J; Eon-Marchais S; Dondon MG; d'Enghien CD; Laugé A; Chemlali W; Raynal V; Labbé M; Bièche I; Baulande S; Bay JO; Berthet P; Caron O; Buecher B; Faivre L; Fresnay M; Gauthier-Villars M; Gesta P; Janin N; Lejeune S; Maugard C; Moutton S; Venat-Bouvet L; Zattara H; Fricker JP; Gladieff L; Coupier I; ; ; ; Chenevix-Trench G; Hall J; Vincent-Salomon A; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Breast Cancer Res; 2018 Apr; 20(1):28. PubMed ID: 29665859
[TBL] [Abstract][Full Text] [Related]
20. Two ATM variants and breast cancer risk.
Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
